Taken together, due to the significant pro-apoptotic efficacy of crocetin in p53-expressing as well as p53-impaired cancer cells, apoptosis targeted by plant-derived compounds should represent a novel strategy in the therapy of malignant diseases, especially human colon cancer [161]. This evidence concerns the gene TP53 and cancer.